Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.

Herrlinger, K R

Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. [electronic resource] - Journal of Crohn's & colitis Sep 2013 - 636-43 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

1876-4479

10.1016/j.crohns.2012.09.016 doi


Adult
Aged
Anti-Inflammatory Agents--therapeutic use
Azathioprine--therapeutic use
Biphenyl Compounds--adverse effects
Blood Sedimentation
C-Reactive Protein--metabolism
Colitis, Ulcerative--blood
Crohn Disease--blood
Dicarboxylic Acids--adverse effects
Dihydroorotate Dehydrogenase
Enzyme Inhibitors--adverse effects
Feces--chemistry
Female
Humans
Immunologic Factors--adverse effects
Immunosuppressive Agents--therapeutic use
Intention to Treat Analysis
Leukocyte L1 Antigen Complex--analysis
Male
Methotrexate--therapeutic use
Middle Aged
Oxidoreductases Acting on CH-CH Group Donors--antagonists & inhibitors
Prednisolone--therapeutic use
Remission Induction
Severity of Illness Index
Young Adult